Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-20
    E.g., 2018-09-20

Archive Search

Pages

38 results
12:00 AM, Sep 05, 2016  |  BC Week In Review | Company News  |  Sales & Marketing

Shire sales and marketing update

a 60-drop container is $426.73. Patients receive one drop of the small molecule integrin beta(2) (LFA-1
12:00 AM, Jul 18, 2016  |  BC Week In Review | Clinical News  |  Regulatory

Xiidra lifitegrast regulatory update

product this quarter. Xiidra is an eye drop formulation of a small molecule integrin beta(2) (LFA-1
12:00 AM, Feb 22, 2016  |  BC Week In Review | Clinical News  |  Regulatory

Lifitegrast regulatory update

Feb. 1, 2016). Lifitegrast is an eye drop formulation of a small molecule integrin beta(2) (LFA-1
12:00 AM, Feb 01, 2016  |  BC Week In Review | Clinical News  |  Regulatory

Lifitegrast regulatory update

Nov. 2, 2015). Lifitegrast is an eye drop formulation of a small molecule integrin beta(2) (LFA-1
12:00 AM, Nov 02, 2015  |  BC Week In Review | Clinical News  |  Clinical Results

Lifitegrast: Phase III data

Lifitegrast ( SHP606 , SAR 1118 )   Business: Ophthalmic   Molecular target: Integrin beta(2) (LFA-1
MAC-1) (CD18)   Description: Eye drop formulation of a small molecule integrin beta(2) (LFA-1; MAC-1; CD18 …
12:00 AM, Oct 26, 2015  |  BC Week In Review | Clinical News  |  Regulatory

Lifitegrast regulatory update

9, 2013). The product is an eye drop formulation of a small molecule integrin beta(2) (LFA-1
12:00 AM, Apr 13, 2015  |  BC Week In Review | Clinical News  |  Regulatory

Lifitegrast regulatory update

25. Shire gained lifitegrast -- an eye drop formulation of a small molecule integrin beta(2) (LFA-1
12:00 AM, Mar 23, 2015  |  BC Week In Review | Clinical News  |  Regulatory

Lifitegrast regulatory update

adults. Shire gained lifitegrast -- an eye drop formulation of a small molecule integrin beta(2) (LFA-1
12:00 AM, May 19, 2014  |  BC Week In Review | Clinical News  |  Regulatory

Lifitegrast regulatory update

scores. Shire gained lifitegrast - an eye drop formulation of a small molecule integrin beta(2) (LFA-1
12:00 AM, May 05, 2014  |  BC Week In Review | Clinical News  |  Clinical Results

Lifitegrast: Phase III data

Lifitegrast ( SHP606 , SAR 1118 )   Business: Ophthalmic   Molecular target: Integrin beta(2) (LFA-1
MAC-1) (CD18)   Description: Eye drop formulation of a small molecule integrin beta(2) (LFA-1; MAC-1; CD18 …

Pages